Main Capital Partners (Main) has backed biomedion, a leading GxP data cloud platform provider.
biomedion offers an extensive suite of software that is deployed across all “good practice” areas (GxP) in the life and health sciences industry, where quality guidelines and regulations are of paramount importance.
biomedion is headquartered in Berlin and has also expanded into the United States with plans to further extend its reach across Europe and North-America.
biomedion represents the third investment from the Main Foundation I fund, which was launched in October 2021 and targets innovative, high-growth software companies.
